婷婷在线观看视频,99热99re8国产在线播放

Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	755038-02-9
Formula :	C₂₈H₃₉N₇O₃
M.W :	521.65
SMILES Code :	O=C(NC1CCN(C)CC1)C2=CC=C(NC(N=C3N(C4CCCC4)[C@@H]5CC)=NC=C3N(C)C5=O)C(OC)=C2
MDL No. :	MFCD10565924
InChI Key :	XQVVPGYIWAGRNI-JOCHJYFZSA-N
Pubchem ID :	11364421

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302
Precautionary Statements:	P280-P305+P351+P338

HeLa cells	0.1 μM	45 min	To study the effect of PLK1 inhibitor on HeLa cells, observed downregulation of PLK1 substrates and upregulation of ATM and ATR substrates.	PMC9876800
hESPL1flox/Δ cells	25 or 200 nM	3 h	To test the critical role of Plk1 in the cell cycle, it was found that Plk1 activity in late G2 or early M phase is essential for centriole disengagement and duplication	PMC2746921
SUM-149 cells	25 nM	7 days	Inhibited PLK1 activity, significantly reduced cell viability	PMC4304881
SUM-149 cells	25 nM	7 days	To evaluate the inhibitory effect of BI 2536 on PLK1 and its impact on cell growth, results showed that SUM-149 cells were more sensitive to BI 2536 than MCF-10A cells.	PMC4304881
bone marrow-derived dendritic cells (BMDCs)	1 μM	2 or 4 h	BI 2536 specifically abrogates transcription of antiviral genes without affecting inflammatory genes following stimulation with LPS, poly(I:C), or Pam3CSK4.	PMC3809888
HeLa cells	250 nM	2 h	Inhibit PLK1 activity and observe cell behavior in prometaphase	PMC4206221
Human pulmonary arterial smooth muscle cells (hPASMCs)	50 nM	24 h	To investigate the effect of BI 2536 on apoptosis in hPASMCs, results showed that BI 2536 significantly induced apoptosis in hPASMCs.	PMC10440037
LNCaP cells	10 nM - 100 nM	24 h	To investigate the effects of BI 2536 on LNCaP cells, results showed that Pim1-overexpressing cells were more sensitive to the inhibitory effects of BI 2536, exhibiting more mitotic arrest and apoptosis.	PMC4086184
Patched mutant tumor cells	0.15 nM - 1.5 μM	48 hours	To evaluate the inhibitory effect of CCT129202 on tumor cell proliferation, results showed significant inhibition of tumor cell proliferation.	PMC3800039

mice	VSV infection model	intravenously	500 μg	3 hours before and 2 hours after infection	BI 2536 inhibits antiviral cytokine mRNA production, while increasing viral replication during in vivo VSV infection.	PMC3809888
Mice	Hypoxia-induced pulmonary hypertension model	Tail vein injection	50 mg/kg	Once per week for 4 weeks	To investigate the therapeutic effect of BI 2536 on hypoxia-induced pulmonary hypertension, results showed that BI 2536 significantly reduced right ventricular systolic pressure (RVSP) and right ventricular hypertrophy (RV/LV + S).	PMC10440037
nude mice	Pim1-overexpressing prostate cancer xenograft model	intravenous injection	25 mg/kg	twice a week for three weeks	To investigate the effects of BI 2536 on Pim1-overexpressing prostate cancer xenograft models, results showed that BI 2536 dramatically inhibited the growth of Pim1-overexpressing tumors and induced more mitotic arrest and apoptosis.	PMC4086184
Nude mice	LS174T colon cancer cell xenograft model	Gavage	30 mg/kg twice a week	Twice a week, for 11 days	Synergistically inhibited tumor growth	PMC8492540

成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

{[proInfo.proName]}

CAS No.: 755038-02-9

Alternative Products

Product Details of BI 2536

Safety of BI 2536

Related Pathways of BI 2536

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT00526149	Breast Cancer ... More >> Endometrial Cancer Head and Neck Cancer Melanoma (Skin) Ovarian Cancer Sarcoma Less <<	Phase 2	Completed	-	Belgium ... More >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 Less <<
NCT00710710	Pancreatic Neoplasms	PHASE2	COMPLETED	2008-10-14	1216.10.43001 Boehringer Ingel... More >>heim Investigational Site, Wien, Austria\|1216.10.49013 Boehringer Ingelheim Investigational Site, Celle, Germany\|1216.10.49009 Boehringer Ingelheim Investigational Site, Düsseldorf, Germany\|1216.10.49007 Boehringer Ingelheim Investigational Site, Essen, Germany\|1216.10.49001 Boehringer Ingelheim Investigational Site, Freiburg/Breisgau, Germany\|1216.10.49005 Boehringer Ingelheim Investigational Site, Hamburg, Germany\|1216.10.49010 Boehringer Ingelheim Investigational Site, Herne, Germany\|1216.10.49008 Boehringer Ingelheim Investigational Site, München, Germany\|1216.10.49003 Boehringer Ingelheim Investigational Site, Stuttgart, Germany\|1216.10.49002 Boehringer Ingelheim Investigational Site, Ulm, Germany Less <<
NCT00412880	Carcinoma, Small Cell	PHASE2	COMPLETED	2008-06-30	1216.11.007 Boehringer Ingelhe... More >>im Investigational Site, Fayetteville, Arkansas, United States\|1216.11.003 Boehringer Ingelheim Investigational Site, Chicago, Illinois, United States\|1216.11.006 Boehringer Ingelheim Investigational Site, Evanston, Illinois, United States\|1216.11.002 Boehringer Ingelheim Investigational Site, Boston, Massachusetts, United States\|1216.11.005 Boehringer Ingelheim Investigational Site, Saint Louis, Missouri, United States\|1216.11.001 Boehringer Ingelheim Investigational Site, Chapel Hill, North Carolina, United States\|1216.11.011 Boehringer Ingelheim Investigational Site, Charleston, South Carolina, United States\|1216.11.010 Boehringer Ingelheim Investigational Site, Greenville, South Carolina, United States\|1216.11.012 Boehringer Ingelheim Investigational Site, Seattle, Washington, United States\|1216.11.009 Alberta Cancer Board, Edmonton, Alberta, Canada Less <<
NCT00243087	Lymphoma	PHASE1	COMPLETED	-	Lombardi Comprehensive Cancer ... More >>Center at Georgetown University Medical Center, Washington, District of Columbia, 20007, United States\|UNMC Eppley Cancer Center at the University of Nebraska Medical Center, Omaha, Nebraska, 68198-6805, United States\|James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York, 14642, United States\|M. D. Anderson Cancer Center at University of Texas, Houston, Texas, 77030-4009, United States Less <<
NCT00706498	Prostatic Neoplasms	PHASE2	COMPLETED	-	1216.19.4407 Boehringer Ingelh... More >>eim Investigational Site, Cambridge, United Kingdom\|1216.19.4405 Boehringer Ingelheim Investigational Site, Guildford, United Kingdom\|1216.19.4402 Boehringer Ingelheim Investigational Site, Headington, United Kingdom\|1216.19.4406 The Christie NHS Foundation Trust, Manchester, United Kingdom\|1216.19.4404 Boehringer Ingelheim Investigational Site, Newcastle Upon Tyne, United Kingdom\|1216.19.4401 Boehringer Ingelheim Investigational Site, Sutton, United Kingdom Less <<
NCT02215044	Pancreatic Neoplasms	Phase 1	Terminated	-	-
NCT02211859	Neoplasms	PHASE1	COMPLETED	-	-
NCT00701766	Leukemia, Myeloid, Acute	PHASE2	COMPLETED	-	1216.20.43001 Boehringer Ingel... More >>heim Investigational Site, Innsbruck, Austria\|1216.20.43002 Boehringer Ingelheim Investigational Site, Wien, Austria\|1216.20.49006 Boehringer Ingelheim Investigational Site, Bonn, Germany\|1216.20.49002 Boehringer Ingelheim Investigational Site, Frankfurt, Germany\|1216.20.49003 Boehringer Ingelheim Investigational Site, Freiburg, Germany\|1216.20.49004 Boehringer Ingelheim Investigational Site, Hannover-Heideviertel, Germany\|1216.20.49007 Boehringer Ingelheim Investigational Site, Heidelberg, Germany\|1216.20.49005 Boehringer Ingelheim Investigational Site, Münster, Germany\|1216.20.49001 Boehringer Ingelheim Investigational Site, Ulm, Germany Less <<
NCT00376623	Carcinoma, Non-Small-Cell Lung	PHASE2	COMPLETED	2008-04-01	1216.9.49002 Boehringer Ingelh... More >>eim Investigational Site, Freiburg, Germany\|1216.9.49007 Boehringer Ingelheim Investigational Site, Gauting, Germany\|1216.9.49008 Boehringer Ingelheim Investigational Site, Gro?hansdorf, Germany\|1216.9.49001 Boehringer Ingelheim Investigational Site, Heidelberg, Germany\|1216.9.49004 Boehringer Ingelheim Investigational Site, Mainz, Germany\|1216.9.49005 Boehringer Ingelheim Investigational Site, Mainz, Germany\|1216.9.49003 Boehringer Ingelheim Investigational Site, Wiesbaden, Germany Less <<
NCT02211872	Neoplasms	Phase 1	Completed	-	-
NCT02211833	Carcinoma, Non-Small-Cell Lung	Phase 1	Completed	-	-

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed